The Medical Device Coordination Group (MDCG) has published the MDCG 2022-21 guidance on the Periodic Safety Update Report (PSUR).

In accordance with Regulation (EU) 2017/745 Article 86, manufacturers of Class IIa, IIb, and III devices are required to draft a PSUR to enable a more consistent, standardized, and systematic review of all Post-Market Surveillance (PMS) data.

The purpose of this guidance is to support manufacturers implementing the requirements for establishing and maintaining the report, providing information on:

  • The minimum expectations for the content and structure of the PSUR,
  • The strategy for grouping devices by PSUR,
  • The cycle for establishing PSURs based on the risk class of devices,
  • PSUR submission procedures, even in the absence of Eudamed.




Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...

Learn more